Kathy Wengel is Executive Vice President & Chief Global Supply Chain Officer for Johnson & Johnson, and a member of the Company’s Executive Committee. She has significant healthcare, operations and global business expertise – with more than three decades of experience in leadership positions with Johnson & Johnson.
In her current role, Kathy is responsible for all aspects of the development and implementation of the global Supply Chain for Johnson & Johnson, as well as its Quality & Compliance, Procurement, Environmental Health & Safety, Sustainability and Engineering & Property Services functions. A strong developer of globally diverse teams, Kathy leads an organization across three business segments: Pharmaceuticals, Medical Devices and Consumer Health.
Under Kathy’s leadership, Johnson & Johnson has been recognized by world-leading groups. The Company has been named #3 in both 2020 and 2021 on the Supply Chain Top 25 list by Gartner, Inc., the world’s leading research and advisory company. It also has the leading number of Lighthouse designations for its use of innovative technologies at production sites and other facilities – a designation granted by the World Economic Forum (WEF). Kathy is also one of the pioneers of the WEF’s Advanced Manufacturing Platform.
Since joining Johnson & Johnson in 1988, Kathy’s responsibilities have grown through a variety of strategic leadership and executive positions across the enterprise in multiple countries and in various roles within operations, quality, engineering, new product development, IT and other business functions. Kathy also served as the first Chief Quality Officer for Johnson & Johnson. During this time, she also co-led the design of the Company’s enterprise Supply Chain and Quality operating model. The effort brought together more than 20 disparate groups, all using core standards and operating principles, while delivering substantial value for the Company over the past decade.
Externally from Johnson & Johnson, Kathy serves as a member of the Board of Directors at LabCorp, a leading global life sciences company dedicated to using science to improve health and improve lives. She also serves as Chair of the Board of GS1 Global, a nonprofit that develops and maintains global supply chain standards. She is the Vice Chair of the Board of Directors at the National Association of Manufacturers in the U.S., and a member of the Board of Directors for the Manufacturing Institute. Kathy serves in several advisory capacities, including as member of the Executive Advisory Board for the Gartner Supply Chain practice and member of the Board of Advisors at AWESOME, a nonprofit working on the advancement of women in senior supply chain roles. Within Johnson & Johnson, Kathy is executive sponsor for the Women’s Leadership & Inclusion (WLI) initiative and the Women in Science, Technology, Engineering, Math, Manufacturing and Design (WiSTEM2D) program.
In 2019, Kathy was recognized by the Council of Supply Management Professionals (CSCMP) with its lifetime Distinguished Service Award, and she was elected to the Supply Chain Hall of Fame, the industry’s top individual supply chain honor. In 2015, Kathy received the National Association of Female Executives’ (NAFE) Women of Excellence Award and AWESOME’s Legendary Leadership Award in 2014.
Kathy holds a BSE degree in civil engineering and operations research from Princeton University.
What is Kathryn E. Wengel's net worth?
The estimated net worth of Kathryn E. Wengel is at least $10.20 million as of June 12th, 2023. Ms. Wengel owns 65,934 shares of Johnson & Johnson stock worth more than $10,204,605 as of November 18th. This net worth estimate does not reflect any other assets that Ms. Wengel may own. Learn More about Kathryn E. Wengel's net worth.
How do I contact Kathryn E. Wengel?
Has Kathryn E. Wengel been buying or selling shares of Johnson & Johnson?
Kathryn E. Wengel has not been actively trading shares of Johnson & Johnson within the last three months. Most recently, Kathryn E. Wengel sold 12,465 shares of the business's stock in a transaction on Monday, June 12th. The shares were sold at an average price of $160.00, for a transaction totalling $1,994,400.00. Following the completion of the sale, the executive vice president now directly owns 65,934 shares of the company's stock, valued at $10,549,440. Learn More on Kathryn E. Wengel's trading history.
Who are Johnson & Johnson's active insiders?
Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.
Are insiders buying or selling shares of Johnson & Johnson?
During the last year, insiders at the sold shares 3 times. They sold a total of 68,757 shares worth more than $10,308,224.54. The most recent insider tranaction occured on August, 30th when VP Robert J Decker sold 5,635 shares worth more than $930,113.10. Insiders at Johnson & Johnson own 0.2% of the company.
Learn More about insider trades at Johnson & Johnson. Information on this page was last updated on 8/30/2024.